MedPath

Effect of a newer drug(magnesium sulfate)given in abdominal cavity at the end of operation for removal of gall bladder through endoscope for providing pain relief

Not Applicable
Registration Number
CTRI/2020/01/022900
Lead Sponsor
Medical CollegeVadodara
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients posted for elective laparoscopic cholecystectomy

American Society of Anaesthesiologists physical status I,II and III

Age from 18 to 65 years

Either sex

Exclusion Criteria

Patient having allergy to study drug(MgSO4 or Bupivacaine)

Patients with liver and Renal failure

Patients with heart block

Chronic alcoholism or drug abuse

Patients receiving any sort of pain medication on chronic basis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the analgesic efficacy and duration of pain relief by measuring following parameters in the postoperative period <br/ ><br> Visual analog score(VAS) <br/ ><br> Time to first requirement of rescue analgesia <br/ ><br> Number of rescue analgesics required in first 24 hours <br/ ><br>Timepoint: 24 hours <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To see the effects of study drugs on vital parameters <br/ ><br>To observe Side effects if any like nausea, vomiting, hypotension, bradycardia, respiratory depression and sedation. <br/ ><br>Timepoint: 24 hours
© Copyright 2025. All Rights Reserved by MedPath